An economic evaluation of risankizumab versus other biologic treatments of moderate to severe plaque psoriasis in Japan.

Hidehisa Saeki,Kanako Ishii,Avani Joshi,Arielle G. Bensimon,Hongbo Yang,Isao Kawaguchi

An economic evaluation of risankizumab versus other biologic treatments of moderate to severe plaque psoriasis in Japan.

2020

Hidehisa Saeki
Kanako Ishii
Avani Joshi
Arielle G. Bensimon
Hongbo Yang
Isao Kawaguchi

AbstractObjective: To evaluate the cost-effectiveness of risankizumab versus other biologic treatments (adalimumab, infliximab, ustekinumab, secukinumab, brodalumab, ixekizumab, and guselkumab) of ...

Keywords:

Brodalumab
Secukinumab
Risankizumab
Adalimumab
Infliximab
Ustekinumab
Guselkumab
Dermatology
Medicine
Ixekizumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations